Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

APVO

Aptevo Therapeutics Inc

May 22 • 04:00PM ET

4.95

-0.09 -1.79 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: IMNN SABS TNXP ONCO BCDA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-203.74	Insider Own	0.06%	Shs Outstand	1.25M	Perf Week	3.77%
Market Cap	6.17M	Forward P/E	-	EPS next Y	-21.46	Insider Trans	0.00%	Shs Float	1.25M	Perf Month	1.33%
Enterprise Value	-3.94M	PEG	-	EPS next Q	-6.41	Inst Own	6.05%	Short Float	7.38%	Perf Quarter	-21.43%
Income	-27.92M	P/S	-	EPS this Y	72.35%	Inst Trans	2.79%	Short Ratio	1.78	Perf Half Y	-77.46%
Sales	0.00M	P/B	0.51	EPS next Y	11.07%	ROA	-197.08%	Short Interest	0.09M	Perf YTD	-47.51%
Book/sh	9.65	P/C	0.42	EPS next 5Y	38.04%	ROE	-549.01%	52W High	235.98 -97.90%	Perf Year	-95.42%
Cash/sh	11.66	P/FCF	-	EPS past 3/5Y	- 89.05%	ROIC	-183.81%	52W Low	3.80 30.26%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.47% 6.63%	Perf 5Y	-100.00%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	99.36%	Oper. Margin	-	ATR (14)	0.35	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.36	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	51.67	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.36	EPS Q/Q	99.60%	SMA20	1.43%	Beta	1.68	Target Price	21.00
Payout	-	Debt/Eq	0.38	Sales Q/Q	-	SMA50	4.74%	Rel Volume	0.51	Prev Close	5.04
Employees	36	LT Debt/Eq	0.30	Earnings	Mar 26 BMO	SMA200	-70.17%	Avg Volume	51.83K	Price	4.95
IPO	Jul 20, 2016	Option/Short	No / Yes	EPS/Sales Surpr.	28458.08% -	Trades		Volume	26,623	Change	-1.79%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)